A newly released peer-reviewed research paper from the United States reveals that Covid patients who received treatment with Remdesivir were approximately five times more likely to die compared to those treated with either Ivermectin or Hydroxychloroquine.
Nonetheless, the situation could potentially be graver than it seems, as the unprocessed data surprisingly don't take into consideration the decrease in the mortality rate over time, or the disparities in fatalities across diverse age groups.
Despite this, the unadjusted data implies that the prohibition of Ivermectin and Hydroxychloroquine, while promoting Remdesivir, could be seen as an act of severe negligence leading to the loss of thousands of lives.
https://www.ispor.org/docs/default-source/intl2023/ispor23wadeposterrwd26-pdf.pdf